Alveolar hemorrhage in anti-basement membrane antibody disease: A series of 28 cases

Medicine

Volumn 86, Issue 3, 2007, Pages 181-193

  Lazor, Romain ^a,e   Bigay Gamé, Laurence ^b   Cottin, Vincent ^a   Cadranel, Jacques ^c   Decaux, Olivier ^d   Fellrath, Jean Marc ^f   Cordier, Jean François ^a,g  

^a UNIVERSITÉ LYON 1   (France)

^b SERVICE DE PNEUMOLOGIE   (France)

^c HÔPITAL TENON   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF BERN   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASEMENT MEMBRANE ANTIBODY; CARBON MONOXIDE; CORTICOSTEROID; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE DISEASE; BASEMENT MEMBRANE ANTIBODY DISEASE; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMOPTYSIS; HUMAN; HYPOXEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; LUNG DISEASE; LUNG FUNCTION TEST; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG VENTILATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SMOKING; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; ADULT; ANOXEMIA; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BIOPSY; BRONCHOALVEOLAR LAVAGE; FATIGUE; FEMALE; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUNG; LUNG DISEASES; MALE; PLASMA EXCHANGE; PULMONARY ALVEOLI; RENAL DIALYSIS; RENAL INSUFFICIENCY; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34249113237     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/md.0b013e318067da56     Document Type: Article

References (71)

1. Addleman M, Logan AS, Grossman RF. Monitoring intrapulmonary hemorrhage in Goodpasture's syndrome. Chest. 1985;87:119-120.
2. Bailey RR, Simpson IJ, Lynn KL, Neale TJ, Doak PB, McGiven AR. Goodpasture's syndrome with normal renal function. Clin Nephrol. 1981;15:211-215.
3. Baldwin GC, Choi R, Roth MD, Shay AH, Kleerup EC, Simmons MS, Tashkin DP. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine. Chest. 2002;121:1231-1238.
4. Ball JA, Young KR Jr. Pulmonary manifestations of Goodpasture's syndrome. Antiglomerular basement membrane disease and related disorders. Clin Chest Med. 1998;19:777-791, ix.
5. Beirne GJ. Goodpasture's syndrome and exposure to solvents. JAMA. 1972;222:1555.
6. Beirne GJ, Brennan JT. Glomerulonephritis associated with hydrocarbon solvents: mediated by antiglomerular basement membrane antibody. Arch Environ Health. 1972;25:365-369.
7. Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM. Idiopathic crescentic glomerulonephritis. Medicine (Baltimore). 1977;56:349-381.
8. Bell DD, Moffatt SL, Singer M, Munt PW. Antibasement membrane antibody disease without clinical evidence of renal disease. Am Rev Respir Dis. 1990;142:234-237.
9. Bombassei GJ, Kaplan AA. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Ind Med. 1992;21:141-153.
10. Bonsib SM, Goeken JA, Kemp JD, Chandran P, Shadur C, Wilson L. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease: report of six cases. Mod Pathol. 1993;6:526-530.
11. Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis. 2005;45:397-406.
12. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, Ingelmo M, Revert L. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in antiglomerular basement membrane disease. Clin Nephrol. 1991;36:107-113.
13. Bouget J, Le Pogamp P, Perrier G, Ramee MP, Rivalan J, Camus C, Thomas R, Chevet D. Glomerulonephrites rapidement progressives a anticorps anti-membrane basale glomerulaire. Ann Med Interne (Paris). 1990;141:409-415.
14. Bowley NB, Hughes JM, Steiner RE. The chest X-ray in pulmonary capillary haemorrhage: correlation with carbon monoxide uptake. Clin Radiol. 1979;30:413-417.
15. Bowley NB, Steiner RE, Chin WS. The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Clin Radiol. 1979;30:419-429.
16. Burke BR, Bear RA. Recurrent Goodpasture's syndrome. Can Med Assoc J. 1983;129:978-979.
17. Carre P, Lloveras JJ, Didier A, Gorguet B, Orfila C, Durand D, Leophonte P. Goodpasture's syndrome with normal renal function. Eur Respir J. 1989;2:911-915.
18. Conlon PJ Jr, Walshe JJ, Daly C, Carmody M, Keogh B, Donohoe J, O'Neill S. Antiglomerular basement membrane disease: the long-term pulmonary outcome. Am J Kidney Dis. 1994;23:794-796.
19. Dahlberg PJ, Kurtz SB, Donadio JV, Holley KE, Velosa JA, Williams DE, Wilson CB. Recurrent Goodpasture's syndrome. Mayo Clin Proc. 1978;53:533-537.
20. Daly C, Conlon PJ, Medwar W, Walshe JJ. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail. 1996;18:105-112.
21. Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. 1983;2:1390-1393.
22. Downie GH, Roholt OA, Jennings L, Blau M, Brentjens JR, Andres GA. Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. II. Role of endothelial damage and repair, induction of autologous phase, and kinetics of antibody deposition in Lewis rats. J Immunol. 1982;129:2647-2652.
23. Fervenza FC, Terreros D, Boutaud A, Hudson BG, Williams RA Jr, Donadio JV Jr, Schwab TR. Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis. 1999;34:549-555.
24. Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis. 1990;142:462-467.
25. Garcia-Rostan y Perez GM, Garcia Bragado F, Puras Gil AM. Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int. 1997;47:692-697.
26. Giri P, Taylor JE. Recurrent Goodpasture's disease with severe renal involvement after initial successful treatment. Nephrol Dial Transplant. 2001;16:1952.
27. Herody M, Bobrie G, Gouarin C, Grunfeld JP, Noel LH. Anti-GBM disease: predictive value of clinical, histological and serological data. Clin Nephrol. 1993;40:249-255.
28. Hind CR, Bowman C, Winearls CG, Lockwood CM. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. Clin Nephrol. 1984;21:244-246.
29. Jayne DR, Marshall PD, Jones SJ, Lockwood CM. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int. 1990;37:965-970.
30. Jennings L, Roholt OA, Pressman D, Blau M, Andres GA, Brentjens JR. Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. J Immunol. 1981;127:129-134.
31. Johnson JP, Moore J Jr, Austin HA III, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore). 1985;64:219-227.
32. Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Neilson EG. Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J Am Soc Nephrol. 1997;8:1795-1800.
33. Keller F, Nekarda H. Fatal relapse in Goodpasture's syndrome 3 years after plasma exchange. Respiration. 1985;48:62-66.
34. Keogh AM, Ibels LS, Allen DH, Isbister JP, Kennedy MC. Exacerbation of Goodpasture's syndrome after inadvertent exposure to hydrocarbon fumes. Br Med J. 1984;288:188.
35. Kim YO, Choi JY, Park JI, Yoon SA, Yang CW, Hyoung K, Bang BK. A case of Goodpasture's syndrome with massive pulmonary hemorrhage. J Korean Med Sci. 2000;15:99-102.
36. Klasa RJ, Abboud RT, Ballon HS, Grossman L. Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature. Am J Med. 1988;84:751-755.
37. Klavis G, Drommer W. Goodpasture-syndrome und Benzineinwirkung. Arch Toxikol. 1970;26:40-55.
38. Kleinknecht D, Morel-Maroger L, Callard P, Adhemar JP, Mahieu P. Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med. 1980;140:230-232.
39. Kovithavongs T, Dossetor JB. Goodpasture's syndrome with normal renal function. Nephrol Dial Transplant. 1997;12:1540-1541.
40. Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P, Guillevin L, Cordier JF. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore). 2000;79:222-233.
41. Lechleitner P, Defregger M, Lhotta K, Totsch M, Fend F. Goodpasture's syndrome. Unusual presentation after exposure to hard metal dust. Chest. 1993;103:956-957.
42. Levy JB, Lachmann RH, Pusey CD. Recurrent Goodpasture's disease. Am J Kidney Dis. 1996;27:573-578.
43. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-1042.
44. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK. Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Br Med J. 1975;2:252-254.
45. Lockwood CM, Bowman C, Bakes D, Pressey A, Dash A. Autoimmunity and glomerulonephritis. Adv Nephrol Necker Hosp. 1987;16:291-306.
46. Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet. 1976;1:711-715.
47. Mathew TH, Hobbs JB, Kalowski S, Sutherland PW, Kincaid-Smith P. Goodpasture's syndrome: normal renal diagnostic findings. Ann Intern Med. 1975;82:215-218.
48. McPhaul JJ Jr, Mullins JD. Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics. J Clin Invest. 1976;57:351-361.
49. Mehler PS, Brunvand MW, Hutt MP, Anderson RJ. Chronic recurrent Goodpasture's syndrome. Am J Med. 1987;82:833-835.
50. Merkel F, Pullig O, Marx M, Netzer KO, Weber M. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. Nephrol Dial Transplant. 1994;9:372-376.
51. Min SA, Rutherford P, Ward MK, Wheeler J, Robertson H, Goodship TH. Goodpasture's syndrome with normal renal function. Nephrol Dial Transplant. 1996;11:2302-2305.
52. Molinier S, Bonnet D, Moulin B, Mianne D, Martet G, Touze JE, Olmer M, de Muizon H. Le syndrome de Goodpasture: role d'un facteur epidemiologique? A propos de deux observations. Rev Med Interne. 1995;16:589-594.
53. Murray RJ, Albin RJ, Mergner W, Criner GJ. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest. 1988;93:427-429.
54. Neary P, Kadlubowski M, Thomson D, Cavaye M, Cumming AD. Antiglomerular basement membrane disease with cANCA positivity without pulmonary involvement. Nephrol Dial Transplant. 1996;11:693-695.
55. O'Donoghue DJ, Short CD, Brenchley PE, Lawler W, Ballardie FW. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol. 1989;32:251-255.
56. Peters DK, Rees AJ, Lockwood CM, Pusey CD. Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc. 1982;14:513-521.
57. Rees AJ, Lockwood CM, Peters DK. Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J. 1977;2:723-726.
58. Schwarz MI, Mortenson RL, Colby TV, Waldron JA, Lynch DA, Hutt MP, Cherniack RM, King TE Jr. Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis. 1993;148:507-511.
59. Serisier DJ, Wong RCW, Armstrong JG. Alveolar haemorrhage in antiglomerular basement membrane disease without detectable antibodies by conventional assays. Thorax. 2006;61:636-639.
60. Shah MK. Outcomes in patients with Goodpasture's syndrome and hydrocarbon exposure. Ren Fail. 2002;24:545-555.
61. Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439-445.
62. Teague CA, Doak PB, Simpson IJ, Rainer SP, Herdson PB. Goodpasture's syndrome: an analysis of 29 cases. Kidney Int. 1978;13:492-504.
63. Tobler A, Schurch E, Altermatt HJ, Im Hof V. Anti-basement membrane antibody disease with severe pulmonary haemorrhage and normal renal function. Thorax. 1991;46:68-70.
64. Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A, Pusey CD. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest. 1992;89:592-601.
65. Verburgh CA, Bruijn JA, Daha MR, van Es LA. Sequential development of anti-GBM nephritis and ANCA-associated pauciimmune glomerulonephritis. Am J Kidney Dis. 1999;34:344-348.
66. Wahls TL, Bonsib SM, Schuster VL. Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. Hum Pathol. 1987;18:202-205.
67. Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol. 1992;2:1227-1234.
68. Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973;3:74-89.
69. Yamamoto T, Wilson CB. Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. Am J Pathol. 1987;126:497-505.
70. Ziesche R, Costabel U, Guzman J, Matthys H. Zytologische und immunzytologische Befunde in der bronchoalveolaren Lavage (BAL) als Beitrag zur Differentialdiagnose chronischer Lungenblutungen. Pneumologie. 1990;44(Suppl 1):299-300.
71. Zimmerman SW, Varanasi UR, Hoff B. Goodpasture's syndrome with normal renal function. Am J Med. 1979;66:163-171.